Philip Morris International Inc.
FDA Authorizes ZYN Nicotine Pouches
Summary
On January 16, 2025, the U.S. Food and Drug Administration (FDA) authorized ZYN nicotine pouches, making them the first and only authorized nicotine pouches in the United States. Swedish Match North America, a subsidiary of Philip Morris International Inc., announced that the FDA's decision recognizes ZYN as a better alternative for adults who smoke or use other traditional tobacco products, providing a science-based solution to help reduce the harm associated with smoking. This authorization impacts all ZYN nicotine pouches currently marketed in the U.S., including various flavors and strengths.
Profitelligence Alerts
Get alerts for PM
Be first to know when Philip Morris International Inc. files with the SEC.
Filing Categories
Exhibits (1)
Advertisement
About Philip Morris International Inc.
Philip Morris International Inc. is a leading global tobacco company primarily engaged in the manufacture and sale of cigarettes and other nicotine-containing products. Known for owning some of the world's best-selling cigarette brands like Marlboro, Philip Morris International plays a significant role in the consumer goods sector. The company's strategic focus includes developing smoke-free alternatives such as heated tobacco systems and e-cigarettes, addressing shifting consumer preferences and regulatory landscapes. Headquartered in New York City, Philip Morris operates in over 180 countries, showcasing a robust international presence. The firm is noteworthy for its commitment to transforming public health narratives within the tobacco industry by advocating for reduced-risk products. As part of its market significance, Philip Morris International drives innovation in tobacco products, influencing regulatory frameworks and competitive dynamics in the global market.
Official SEC Documents
Advertisement